Plavix Den europeiske union - norsk - EMA (European Medicines Agency)

plavix

sanofi winthrop industrie - klopidogrelhydrogensulfat - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antithrombotic agents - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. forebygging av atherothrombotic og tromboemboliske hendelser i atrial fibrillationin voksne pasienter med atrieflimmer som har minst en risikofaktor for vaskulære hendelser, er ikke egnet for behandling med vitamin-k-antagonister og som har en lav risiko for blødning, clopidogrel er indisert i kombinasjon med asa for forebygging av atherothrombotic og tromboemboliske hendelser, inkludert hjerneslag.

Xarelto Den europeiske union - norsk - EMA (European Medicines Agency)

xarelto

bayer ag - rivaroksaban - arthroplasty, replacement; venous thromboembolism - antithrombotic agents - xarelto, co-gis med acetylsalisylsyre (asa) alene eller sammen med asa pluss clopidogrel eller tiklopidin, er indikert for forebygging av atherothrombotic hendelser hos voksne pasienter etter et akutt koronar syndrom (acs) med forhøyet ved biomarkører. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. forebygging av venøs tromboembolisme (vte) hos voksne pasienter som gjennomgår valgfri hofte- eller kneutskifting. behandling av dyp venetrombose (dvt) og lungeemboli (pe), og forebygging av tilbakevendende dvt og pe i voksne. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Diprasorin 200 mg / 25 mg Norge - norsk - Statens legemiddelverk

diprasorin 200 mg / 25 mg

orion corporation - espoo - dipyridamol / acetylsalisylsyre - kapsel med modifisert frisetting, hard - 200 mg / 25 mg

Paralen Norge - norsk - Statens legemiddelverk

paralen

opella healthcare france sas - paracetamol / acetylsalisylsyre / koffein - tablett - 250 mg / 250 mg / 50 mg

Actikerall 5 mg/ g / 100 mg/ g Norge - norsk - Statens legemiddelverk

actikerall 5 mg/ g / 100 mg/ g

almirall hermal gmbh - fluorouracil / salisylsyre - liniment, oppløsning - 5 mg/ g / 100 mg/ g

Dermanolon vet 1.77 mg/ ml / 17.7 mg/ ml Norge - norsk - Statens legemiddelverk

dermanolon vet 1.77 mg/ ml / 17.7 mg/ ml

le vet beheer b.v. - triamcinolonacetonid / salisylsyre - hudspray, oppløsning - 1.77 mg/ ml / 17.7 mg/ ml

Recicort vet 1.77 mg/ ml / 17.7 mg/ ml Norge - norsk - Statens legemiddelverk

recicort vet 1.77 mg/ ml / 17.7 mg/ ml

le vet beheer b.v. - triamcinolonacetonid / salisylsyre - Øredråper, oppløsning - 1.77 mg/ ml / 17.7 mg/ ml

Clopidogrel Acino Den europeiske union - norsk - EMA (European Medicines Agency)

clopidogrel acino

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Asasantin Retard 200 mg / 25 mg Norge - norsk - Statens legemiddelverk

asasantin retard 200 mg / 25 mg

boehringer ingelheim international gmbh - dipyridamol / acetylsalisylsyre - kapsel med modifisert frisetting, hard - 200 mg / 25 mg

Diprosalic 0.5 mg/ g / 30 mg/ g Norge - norsk - Statens legemiddelverk

diprosalic 0.5 mg/ g / 30 mg/ g

n.v. organon - kloosterstraat - betametasondipropionat / salisylsyre - salve - 0.5 mg/ g / 30 mg/ g